IS6772A - Kristallað mónóhýdrat, aðferð við að framleiða það og notkun þess í framleiðslu á lyfi - Google Patents

Kristallað mónóhýdrat, aðferð við að framleiða það og notkun þess í framleiðslu á lyfi

Info

Publication number: IS6772A
Authority: IS; Iceland
Prior art keywords: preparation; medicament; manufacture; crystalline monohydrate; bromide
Prior art date: 2000-10-12

Application number

IS6772A

Other languages

English (en)

Other versions

IS2339B (is

Inventor

Banholzer Rolf

Sieger Peter

Kulinna Christian

Trunk Michael

Ludwig August Graulich Manfred

Specht Peter

Meissner Helmut

Mathes Andreas

Original Assignee

Boehringer Ingelheim Pharma Gmbh & Co. Kg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-12

Filing date

2003-04-09

Publication date

2003-04-09

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7659568&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS6772(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-04-09 Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg

2003-04-09 Publication of IS6772A publication Critical patent/IS6772A/is

2008-02-15 Publication of IS2339B publication Critical patent/IS2339B/is

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

IS6772A 2000-10-12 2003-04-09 Kristallað tíótrópíumbrómíðmónóhýdrat, aðferð viðað framleiða það og notkun þess í framleiðslu á lyfi IS2339B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10050621		2000-10-12
PCT/EP2001/011225 WO2002030928A1 (de)	2000-10-12	2001-09-28	Kristallines monohydrat, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels

Publications (2)

Publication Number	Publication Date
IS6772A true IS6772A (is)	2003-04-09
IS2339B IS2339B (is)	2008-02-15

Family

ID=7659568

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6772A IS2339B (is)	2000-10-12	2003-04-09	Kristallað tíótrópíumbrómíðmónóhýdrat, aðferð viðað framleiða það og notkun þess í framleiðslu á lyfi

Country Status (47)

Country	Link
EP (2)	EP1326862B1 (is)
JP (1)	JP3764422B2 (is)
KR (1)	KR100823860B1 (is)
CN (2)	CN100519558C (is)
AP (1)	AP1572A (is)
AR (2)	AR034389A1 (is)
AT (1)	ATE276253T1 (is)
AU (2)	AU1499602A (is)
BG (1)	BG66161B1 (is)
BR (1)	BR0114584A (is)
CA (1)	CA2425539C (is)
CR (1)	CR6938A (is)
CZ (1)	CZ301841B6 (is)
DE (1)	DE50103666D1 (is)
DK (1)	DK1326862T3 (is)
DZ (1)	DZ3478A1 (is)
EA (1)	EA004381B1 (is)
EC (1)	ECSP034540A (is)
EE (1)	EE04567B1 (is)
EG (1)	EG24142A (is)
ES (1)	ES2228965T3 (is)
GE (1)	GEP20063905B (is)
HK (2)	HK1060567A1 (is)
HR (1)	HRP20030276B1 (is)
HU (1)	HU226830B1 (is)
IL (2)	IL155335A0 (is)
IS (1)	IS2339B (is)
MA (1)	MA25842A1 (is)
ME (2)	MEP40008A (is)
MX (1)	MXPA03003221A (is)
MY (1)	MY126931A (is)
NO (1)	NO328465B1 (is)
NZ (1)	NZ525733A (is)
OA (1)	OA12403A (is)
PE (1)	PE20020422A1 (is)
PL (1)	PL207870B1 (is)
PT (1)	PT1326862E (is)
RS (1)	RS50218B (is)
SA (1)	SA01220412B1 (is)
SI (1)	SI1326862T1 (is)
SK (1)	SK287009B6 (is)
TR (1)	TR200402579T4 (is)
TW (1)	TW589313B (is)
UA (1)	UA74215C2 (is)
UY (2)	UY26962A1 (is)
WO (1)	WO2002030928A1 (is)
ZA (1)	ZA200302500B (is)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6608055B2 (en)	2001-06-22	2003-08-19	Boehringer Ingelheim Pharma Kg	Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
RS50441B (sr) *	2001-06-22	2010-03-02	Boehringer Ingelheim Pharma Gmbh. & Co.Kg.	Kristalni antiholinergik, postupak za njegovo pripremanje i njegova primena u proizvodnji leka
DE10212264A1 (de)	2002-03-20	2003-10-02	Boehringer Ingelheim Pharma	Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
DE10214263A1 (de) *	2002-03-28	2003-10-16	Boehringer Ingelheim Pharma	HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
US7244415B2 (en)	2002-03-28	2007-07-17	Boehringer Ingelheim Pharma Gmbh & Co. Kg	HFA suspension formulations of an anhydrate
US7311894B2 (en)	2002-03-28	2007-12-25	Boehringer Ingelheim Pharma Gmbh & Co. Kg	HFA suspension formulations containing an anticholinergic
US7056916B2 (en)	2002-11-15	2006-06-06	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Medicaments for the treatment of chronic obstructive pulmonary disease
DE10317461A1 (de)	2003-04-16	2004-10-28	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
SG137859A1 (en)	2003-11-03	2007-12-28	Boehringer Ingelheim Int	Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
ATE453641T1 (de) *	2003-11-03	2010-01-15	Boehringer Ingelheim Int	Neues kristallines anhydrat mit anticholinerger wirksamkeit
SG149876A1 (en) *	2003-11-03	2009-02-27	Boehringer Ingelheim Int	Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
US7968717B2 (en)	2003-11-03	2011-06-28	Boehringer Ingelhein International Gmbh	Crystalline anhydrate with anticholinergic efficacy
DE102004016179A1 (de) *	2004-03-30	2005-10-20	Boehringer Ingelheim Pharma	Verbindungen zur Behandlung von proliferativen Prozessen
KR101287460B1 (ko)	2004-04-22	2013-07-23	베링거 인겔하임 인터내셔날 게엠베하	벤즈옥사진을 함유하는 호흡기 질환 치료용 약제학적배합물
DE102004024454A1 (de)	2004-05-14	2005-12-08	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US7220742B2 (en)	2004-05-14	2007-05-22	Boehringer Ingelheim International Gmbh	Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE602004020337D1 (de)	2004-08-11	2009-05-14	Boehringer Ingelheim Pharma	Anticholinergika enthaltende Arzneimittel zur Behandlung von Krankheiten der ableitenden Harnwege
US20060079544A1 (en) *	2004-08-13	2006-04-13	Boehringer Ingelheim International Gmbh	Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
DE102004048389A1 (de)	2004-10-01	2006-04-06	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
BRPI0517282A (pt) *	2004-10-21	2008-10-07	Boehringer Ingelheim Int	blister para inaladores
WO2006094924A2 (en) *	2005-03-09	2006-09-14	Boehringer Ingelheim International Gmbh	New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors
CA2605688A1 (en)	2005-04-28	2006-11-02	Boehringer Ingelheim International Gmbh	Compounds for treating inflammatory diseases
CN101166738B (zh)	2005-05-02	2011-06-01	贝林格尔·英格海姆国际有限公司	噻托溴铵的新晶型
MX2007013691A (es) *	2005-05-02	2008-01-21	Boehringer Ingelheim Int	Nuevas formas cristalinas de bromuro de tiotropio.
NZ583872A (en) *	2005-06-15	2011-10-28	Boehringer Ingelheim Int	Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof
DE102005030733A1 (de)	2005-07-01	2007-01-04	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
KR20080039974A (ko) *	2005-08-06	2008-05-07	베링거 인겔하임 인터내셔날 게엠베하	중증 지속성 천식의 치료에서 티오트로퓸 염의 용도
KR101360803B1 (ko)	2005-08-15	2014-02-11	베링거 인겔하임 인터내셔날 게엠베하	베타모방제의 제조방법
TWI396541B (zh)	2005-10-10	2013-05-21	Boehringer Ingelheim Int	用於治療呼吸疾病之新穎藥物組合
US7423146B2 (en)	2005-11-09	2008-09-09	Boehringer Ingelheim International Gmbh	Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
DE102005059602A1 (de) *	2005-12-14	2007-06-21	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Mikronisierung
WO2007075838A2 (en) *	2005-12-19	2007-07-05	Sicor Inc.	Pure and stable tiotropium bromide
ES2396978T5 (es)	2005-12-19	2015-12-04	Sicor, Inc.	Forma cristalina novedosa de bromuro de tiotropio y procedimiento para la preparación de la misma
EA015353B1 (ru) *	2006-01-04	2011-06-30	Бёрингер Ингельхайм Интернациональ Гмбх	Применение солей тиотропия для лечения персистирующей астмы средней тяжести
NZ563488A (en)	2006-04-19	2010-04-30	Boehringer Ingelheim Int	Dihydrothienopyrimidines for the treatment of inflammatory diseases
EP1847543A1 (de)	2006-04-19	2007-10-24	Boehringer Ingelheim Pharma GmbH & Co. KG	Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
US20080051582A1 (en)	2006-07-10	2008-02-28	Sicor Inc.	Process for the preparation of tiotropium bromide
WO2008017637A1 (de)	2006-08-07	2008-02-14	Boehringer Ingelheim International Gmbh	Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
UY30550A1 (es)	2006-08-22	2008-03-31	Boehringer Ingelheim Int	Nuevos beta-agonistas enantioméricamente puros, procedimientos para su preparacion y su uso como medicamentos
EP1923393A1 (en) *	2006-11-17	2008-05-21	Boehringer Ingelheim Pharma GmbH & Co. KG	Crystalline form of tiotropium bromide and urea
EP1925295A1 (de) *	2006-11-22	2008-05-28	Boehringer Ingelheim Pharma GmbH & Co. KG	Stabile Pulverformulierung enthaltend ein Anticholinergikum
GB0716026D0 (en) *	2007-08-16	2007-09-26	Norton Healthcare Ltd	An inhalable medicament
EP2215092B1 (de)	2007-10-19	2012-01-25	Boehringer Ingelheim International GmbH	Substituierte piperidino-dihydrothienopyrimidine
EP2093219A1 (de)	2008-02-22	2009-08-26	Boehringer Ingelheim International Gmbh	Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel
US20100272811A1 (en) *	2008-07-23	2010-10-28	Alkermes,Inc.	Complex of trospium and pharmaceutical compositions thereof
KR101754698B1 (ko)	2008-12-19	2017-07-26	센트렉시온 테라퓨틱스 코포레이션	염증, 천식 및 ｃｏｐｄ 치료용 ｃｃｒ2 수용체 길항제로서의 사이클릭 피리미딘-4-카복스아미드
EP2201934A1 (en)	2008-12-23	2010-06-30	CHIESI FARMACEUTICI S.p.A.	Tiotropium aerosol formulation products with improved chemical stability
EP2403851B1 (en)	2009-03-06	2015-06-17	Mahmut Bilgic	New crystalline forms of tiotropium bromide
WO2011015883A1 (en)	2009-08-07	2011-02-10	Generics [Uk] Limited	Dichloromethane solvate of tiotropium bromide and its use
NZ624602A (en)	2009-08-07	2015-11-27	Generics Uk Ltd	Anhydrate of tiotropium bromide
US20130143905A1 (en)	2009-12-17	2013-06-06	Boehringer Ingelheim International Gmbh	Novel antagonists for ccr2 and uses thereof
EA024397B1 (ru)	2009-12-17	2016-09-30	Сентрекшн Терапьютикс Корпорейшн	Новые антагонисты рецептора ccr2 и их применение
NZ600857A (en)	2010-01-29	2014-06-27	Boehringer Ingelheim Int	Substituted naphthyridines and their use as syk kinase inhibitors
EP2569298B1 (en)	2010-05-12	2015-11-25	Boehringer Ingelheim International GmbH	Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
EP2569295B1 (en)	2010-05-12	2014-11-19	Boehringer Ingelheim International GmbH	New ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
EP2571870B1 (en)	2010-05-17	2015-01-21	Boehringer Ingelheim International GmbH	Ccr2 antagonists and uses thereof
EP2576542B1 (en)	2010-05-25	2015-04-22	Boehringer Ingelheim International GmbH	Cyclic amide derivatives of pyridazine-3-carboxylic acids and their use in the treatment of pulmonary, pain, immune related and cardiovascular diseases
US8962656B2 (en)	2010-06-01	2015-02-24	Boehringer Ingelheim International Gmbh	CCR2 antagonists
EP2668177B1 (en)	2011-01-28	2014-10-22	Boehringer Ingelheim International GmbH	Substituted pyridinyl-pyrimidines and their use as medicaments
TR201102068A2 (tr) *	2011-03-03	2012-09-21	Bi̇lgi̇ç Mahmut	Tiotropyum bromür içeren kristal maddeler
WO2012171863A1 (en)	2011-06-16	2012-12-20	Boehringer Ingelheim International Gmbh	New selective ccr2 antagonists
WO2013010839A1 (en)	2011-07-15	2013-01-24	Boehringer Ingelheim International Gmbh	Novel and selective ccr2 antagonists
MX336224B (es)	2011-07-26	2016-01-12	Boehringer Ingelheim Int	Quinolinas sustituidas y su uso como medicamentos.
US20130059866A1 (en)	2011-08-24	2013-03-07	Boehringer Ingelheim International Gmbh	Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
CZ304368B6 (cs)	2011-11-28	2014-04-02	Zentiva, K.S.	Směsný solvát tiotropium bromidu a způsob jeho přípravy
GB201200525D0 (en)	2011-12-19	2012-02-29	Teva Branded Pharmaceutical Prod R & D Inc	An inhalable medicament
US9096579B2 (en)	2012-04-20	2015-08-04	Boehringer Ingelheim International Gmbh	Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
UA115888C2 (uk)	2012-11-05	2018-01-10	Зентіва, К.С.	Стабілізація сольватів тіотропію
EP2913332A1 (en) *	2014-02-27	2015-09-02	Euticals S.P.A.	Crystalline form of tiotropium bromide with lactose
EP3119765B1 (en)	2014-03-19	2019-07-17	Boehringer Ingelheim International GmbH	Heteroaryl syk inhibitors
US10034866B2 (en)	2014-06-19	2018-07-31	Teva Branded Pharmaceutical Products R&D, Inc.	Inhalable medicament comprising tiotropium
RU2567539C1 (ru) *	2015-02-04	2015-11-10	Индивидуальный предприниматель Михайлов Олег Ростиславович	КРИСТАЛЛИЧЕСКАЯ γ-МОДИФИКАЦИЯ (1α,2β,4β,5α,7β-7)-[(ГИДРОКСИДИ-2-ТИЕНИЛАЦЕТИЛ)ОКСИ]-9,9-ДИМЕТИЛ-3-ОКСА-9-АЗОНИАТРИЦИКЛО[3.3.1.02,4]НОНАН БРОМИДА МОНОГИДРАТА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ЕЁ ОСНОВЕ
EP3414243A1 (en)	2016-02-11	2018-12-19	Sima Patent Ve Lisanslama Hizmetleri Ltd. STI	Crystalline form of tiotropium bromide anhydrate
EP3430011A4 (en) *	2016-11-04	2019-08-14	Sima Patent Ve Lisanslama Hizmetleri Ltd. STI	NOVEL ACTIVE SUBSTANCE

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3931041C2 (de) *	1989-09-16	2000-04-06	Boehringer Ingelheim Kg	Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
SK280911B6 (sk) *	1992-12-09	2000-09-12	Boehringer Ingelheim Pharmaceuticals, Inc.	Farmaceutický prostriedok
DE19834506A1 (de) *	1998-07-31	2000-02-03	Hexal Ag	Transmucosales therapeutisches System zur Anwendung von Sildenafil
PT1102579E (pt) *	1998-08-04	2003-07-31	Jago Res Ag	Formulacoes de aerossol medicinais

2001
- 2001-09-28 ME MEP-400/08A patent/MEP40008A/xx unknown
- 2001-09-28 CA CA002425539A patent/CA2425539C/en not_active Expired - Lifetime
- 2001-09-28 ME MEP-2008-400A patent/ME00243B/me unknown
- 2001-09-28 TR TR2004/02579T patent/TR200402579T4/xx unknown
- 2001-09-28 IL IL15533501A patent/IL155335A0/xx active IP Right Grant
- 2001-09-28 CZ CZ20031025A patent/CZ301841B6/cs not_active IP Right Cessation
- 2001-09-28 BR BR0114584-3A patent/BR0114584A/pt active Pending
- 2001-09-28 AU AU1499602A patent/AU1499602A/xx active Pending
- 2001-09-28 CN CNB2005100977370A patent/CN100519558C/zh not_active Ceased
- 2001-09-28 PT PT01983510T patent/PT1326862E/pt unknown
- 2001-09-28 UA UA2003054185A patent/UA74215C2/uk unknown
- 2001-09-28 EE EEP200300171A patent/EE04567B1/xx unknown
- 2001-09-28 DE DE50103666T patent/DE50103666D1/de not_active Expired - Lifetime
- 2001-09-28 EA EA200300457A patent/EA004381B1/ru not_active IP Right Cessation
- 2001-09-28 SK SK436-2003A patent/SK287009B6/sk not_active IP Right Cessation
- 2001-09-28 HU HU0301022A patent/HU226830B1/hu unknown
- 2001-09-28 KR KR1020037005083A patent/KR100823860B1/ko active IP Right Grant
- 2001-09-28 AP APAP/P/2003/002775A patent/AP1572A/en active Active
- 2001-09-28 MX MXPA03003221A patent/MXPA03003221A/es active IP Right Grant
- 2001-09-28 DZ DZ013478A patent/DZ3478A1/fr active
- 2001-09-28 JP JP2002534314A patent/JP3764422B2/ja not_active Expired - Lifetime
- 2001-09-28 OA OA1200300107A patent/OA12403A/fr unknown
- 2001-09-28 EP EP01983510A patent/EP1326862B1/de not_active Expired - Lifetime
- 2001-09-28 NZ NZ525733A patent/NZ525733A/en not_active IP Right Cessation
- 2001-09-28 WO PCT/EP2001/011225 patent/WO2002030928A1/de active IP Right Grant
- 2001-09-28 DK DK01983510T patent/DK1326862T3/da active
- 2001-09-28 CN CNB018171435A patent/CN1221549C/zh not_active Ceased
- 2001-09-28 EP EP04016877A patent/EP1468998A1/de not_active Withdrawn
- 2001-09-28 AU AU2002214996A patent/AU2002214996B2/en not_active Expired
- 2001-09-28 ES ES01983510T patent/ES2228965T3/es not_active Expired - Lifetime
- 2001-09-28 AT AT01983510T patent/ATE276253T1/de active
- 2001-09-28 GE GE5214A patent/GEP20063905B/en unknown
- 2001-09-28 SI SI200130219T patent/SI1326862T1/xx unknown
- 2001-09-28 PL PL366041A patent/PL207870B1/pl unknown
- 2001-09-28 RS YU27303A patent/RS50218B/sr unknown
- 2001-10-02 SA SA01220412A patent/SA01220412B1/ar unknown
- 2001-10-09 TW TW090124963A patent/TW589313B/zh active
- 2001-10-09 EG EG20011058A patent/EG24142A/xx active
- 2001-10-10 MY MYPI20014705A patent/MY126931A/en unknown
- 2001-10-10 PE PE2001001000A patent/PE20020422A1/es active IP Right Grant
- 2001-10-10 UY UY26962A patent/UY26962A1/es not_active Application Discontinuation
- 2001-10-12 AR ARP010104782A patent/AR034389A1/es active Pending
2003
- 2003-03-26 CR CR6938A patent/CR6938A/es unknown
- 2003-03-28 BG BG107687A patent/BG66161B1/bg active Active
- 2003-03-31 ZA ZA200302500A patent/ZA200302500B/en unknown
- 2003-04-07 EC EC2003004540A patent/ECSP034540A/es unknown
- 2003-04-08 MA MA27102A patent/MA25842A1/fr unknown
- 2003-04-09 IS IS6772A patent/IS2339B/is unknown
- 2003-04-10 HR HR20030276A patent/HRP20030276B1/xx not_active IP Right Cessation
- 2003-04-10 IL IL155335A patent/IL155335A/en unknown
- 2003-04-11 NO NO20031694A patent/NO328465B1/no not_active IP Right Cessation
2004
- 2004-05-20 HK HK04103583A patent/HK1060567A1/xx not_active IP Right Cessation
2006
- 2006-06-07 HK HK06106478.2A patent/HK1086557A1/xx not_active IP Right Cessation
2008
- 2008-09-19 AR ARP080104109A patent/AR068527A2/es unknown
2013
- 2013-07-11 UY UY34901A patent/UY34901A/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
HUP0301022A2 (hu)	2003-10-28
CN1733761A (zh)	2006-02-15
CZ301841B6 (cs)	2010-07-07
AU1499602A (en)	2002-04-22
MY126931A (en)	2006-10-31
RS50218B (sr)	2009-07-15
MXPA03003221A (es)	2004-12-03
MA25842A1 (fr)	2003-07-01
EE04567B1 (et)	2005-12-15
ECSP034540A (es)	2003-07-25
MEP40008A (en)	2011-02-10
BG66161B1 (bg)	2011-09-30
AP1572A (en)	2006-02-13
TW589313B (en)	2004-06-01
ES2228965T3 (es)	2005-04-16
JP3764422B2 (ja)	2006-04-05
SK4362003A3 (en)	2003-08-05
EA004381B1 (ru)	2004-04-29
WO2002030928A1 (de)	2002-04-18
HUP0301022A3 (en)	2005-12-28
AU2002214996B2 (en)	2007-03-15
ZA200302500B (en)	2004-04-22
BR0114584A (pt)	2003-08-26
AP2003002775A0 (en)	2003-03-31
AR068527A2 (es)	2009-11-18
IL155335A0 (en)	2003-11-23
YU27303A (sh)	2006-05-25
PE20020422A1 (es)	2002-06-28
UY26962A1 (es)	2002-06-20
BG107687A (bg)	2003-09-30
CA2425539A1 (en)	2003-04-11
UA74215C2 (uk)	2005-11-15
NO20031694D0 (no)	2003-04-11
TR200402579T4 (tr)	2004-12-21
IL155335A (en)	2009-02-11
EP1468998A1 (de)	2004-10-20
CN1221549C (zh)	2005-10-05
EE200300171A (et)	2003-06-16
GEP20063905B (en)	2006-08-25
UY34901A (es)	2015-02-27
PT1326862E (pt)	2004-11-30
PL366041A1 (en)	2005-01-24
DK1326862T3 (da)	2004-11-22
KR100823860B1 (ko)	2008-04-21
EG24142A (en)	2008-08-06
SI1326862T1 (en)	2005-02-28
HRP20030276A2 (en)	2005-02-28
OA12403A (en)	2006-04-18
IS2339B (is)	2008-02-15
HK1060567A1 (en)	2004-08-13
CN100519558C (zh)	2009-07-29
CR6938A (es)	2004-10-28
PL207870B1 (pl)	2011-02-28
KR20030042008A (ko)	2003-05-27
NO20031694L (no)	2003-04-11
HRP20030276B1 (en)	2006-02-28
HK1086557A1 (en)	2006-09-22
CN1469877A (zh)	2004-01-21
SK287009B6 (sk)	2009-09-07
JP2004526668A (ja)	2004-09-02
EA200300457A1 (ru)	2003-10-30
DE50103666D1 (de)	2004-10-21
CA2425539C (en)	2007-04-03
DZ3478A1 (fr)	2002-04-18
AR034389A1 (es)	2004-02-25
NZ525733A (en)	2005-01-28
EP1326862B1 (de)	2004-09-15
SA01220412B1 (ar)	2006-11-05
HU226830B1 (en)	2009-11-30
NO328465B1 (no)	2010-02-22
ME00243B (me)	2011-05-10
ATE276253T1 (de)	2004-10-15
EP1326862A1 (de)	2003-07-16

Publication	Publication Date	Title
IS6772A (is)	2003-04-09	Kristallað mónóhýdrat, aðferð við að framleiða það og notkun þess í framleiðslu á lyfi
HRP20031066B1 (en)	2011-10-31	Crystalline anticholinergic, method for its production, and use thereof in the production of a drug
DK1385519T3 (da)	2006-11-13	Tiotropiumsalte til behandling af inflammatoriske sygdomme
EE05287B1 (et)	2010-04-15	Tsklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
CY1105210T1 (el)	2010-03-03	Μεθοδος για την παρασκευη προδρομου ενωσης του αντιχολινενepγου tiotropiumbromid
EE200200656A (et)	2004-06-15	Ravis kasutatavad tropaani derivaadid
NO20040968L (no)	2004-05-05	Opioidagonistpreparater med frigjorbar og sekvestrert antagonist
CY1110289T1 (el)	2015-01-14	Φαρμακευτικη συνθεση για τη θεραπεια ρινιτιδων
IS2216B (is)	2007-03-15	Meðferðaráform við inngjöf á H+,K+ -ATPasa-hemla
ATE367152T1 (de)	2007-08-15	Herstellungsverfahren für niedrig dosierte pharmazeutische zusammensetzung
ECSP066318A (es)	2006-07-28	Composición para la liberación de una base debil por un periodo extendido de tiempo
EA200401303A1 (ru)	2005-04-28	Лекарственные средства, содержащие стероиды и новое антихолинергическое средство
ATE343576T1 (de)	2006-11-15	7-azaindolderivate als cox2-inhibitoren
IT1320192B1 (it)	2003-11-26	Composizione terapeutica per la cura della psoriasi.
ITTO20020582A1 (it)	2004-01-05	Nuovo uso della rapamicina e di suoi analoghi strutturali
EA200400382A1 (ru)	2004-10-28	Применение специфической дозы фондапаринукса натрия для лечения окс
PT1474415E (pt)	2011-10-13	Derivados de benzimidazol substituídos em 1-fenilo-2- heteroarilo, o seu uso para a produção de fármacos para o tratamento de doenças imunológicas
AR038320A1 (es)	2005-01-12	Una dosis de sanorg 34006 para el uso en el tratamiento y profilaxis secundaria de eventos tromboembolicos venosos en pacientes con trombosis venosa profunda
RU2000114403A (ru)	2002-06-20	Способ лечения язвенной болезни луковицы двенадцатиперстной кишки, осложненной стенозом
ITRM20020257A0 (it)	2002-05-09	Impiego della forma stabile della prostaciclina i2 (iloprost) nel trattamento della generazione maculare senile non essudativa.
UA2986U (uk)	2004-09-15	Спосіб лікування розсіяного склерозу
RU2000130337A (ru)	2003-08-10	Способ лечения острых воспалительных заболеваний верхнечелюстных пазух